Valdecoxib
Valdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about possible increased risk of heart attack and stroke.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
314.36
Molecular Formula
C16H14N2O3S
Notes
Research use only, not for human use.
Receptor
COX-2
CAS Number
181695-72-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
